Sun Pharmaceutical Industries declines on getting warning letter from USFDA for Dadra facility

20 Jun 2024 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 1481.00, down by 23.15 points or 1.54% from its previous closing of Rs. 1504.15 on the BSE.

The scrip opened at Rs. 1489.95 and has touched a high and low of Rs. 1489.95 and Rs. 1475.55 respectively. So far 26550 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1638.70 on 05-Apr-2024 and a 52 week low of Rs. 977.50 on 23-Jun-2023.

Last one week high and low of the scrip stood at Rs. 1530.00 and Rs. 1475.55 respectively. The current market cap of the company is Rs. 355317.52 crore.

The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.54% and 8.97% respectively.

Sun Pharmaceutical Industries has received warning letter from US Food and Drug Administration (USFDA) for its Dadra facility. The Warning Letter summarizes violations with respect to Current Good Manufacturing Practice (cGMP) regulations. The contents of the Warning Letter shall be made public by the USFDA in due course. 

In April 2024, USFDA has issued Official Action Indicated (OAI) status to Dadra facility. USFDA had conducted an inspection at Company’s Dadra facility from December 4, 2023 to December 15, 2023.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×